Neuroprotection and Precision

The company's pipeline includes Privosegtor for neuroprotection in optic neuritis and potential applications in other neuro‑ophthalmic and neurological indications. Licaminlimab is being developed as a precision medicine treatment for dry eye disease with a genotype‑based approach.